Case number 1:17-cv-01690
Takeda Pharmaceuticals U.S.A., Inc. v. Strides Pharma Global PTE Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 6, 2018 | 13 | Main Document (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,906,519; 7,935,731; 8,093,298; 7,964,648; 8,093,297; US 7,619,004; US 7,601,758; US 7,820,681; US 7,915,269; US 7,964,647; US 7,981,938; US 8,093,296; US 8,097,655; US 8,415,395; US 8,415,396; US 8,440,721; US 8,440,722. (Attachments: # (1) Order)(nms) |
| Jul 6, 2018 | 13 | Order (2) |
| Jul 6, 2018 | 13 | Patent/Trademark Report to Commissioner (2) |
| Jul 6, 2018 | 12 | Order (2) Docket Text: SO ORDERED Granting [11] Stipulation of Dismissal without prejudice (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 7/6/2018. (nms) |
| Jul 5, 2018 | 11 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal without Prejudice and Proposed Order, by Takeda Pharmaceuticals U.S.A., Inc.. (Attaway, Daniel) Modified on 7/6/2018 (nms). |
| May 18, 2018 | 10 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order to Stay Action Pending Regulatory Review of Settlement by Takeda Pharmaceuticals U.S.A., Inc.. (Attaway, Daniel) |
| May 18, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [10] Stipulation and Order to Stay Action Pending Regulatory Review of Settlement. Signed by Judge Richard G. Andrews on 5/18/2018. (nms) |
| Feb 20, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Heather E. Takahashi, Jeffrey I. Weinberger, Ted G. Dane, Elizabeth A. Laughton, and Hannah Dubina for Takeda Pharmaceuticals U.S.A., Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
| Jan 25, 2018 | N/A | SO ORDERED (0) |
| Jan 25, 2018 | 9 | Motion for Leave to Appear Pro Hac Vice (7) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jeffrey I. Weinberger, Ted G. Dane, Heather E. Takahashi, Elizabeth A. Laughton, and Hannah Dubina - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Attaway, Daniel) |
| Jan 17, 2018 | 8 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Strides Arcolab International Ltd., U.K. for Strides Pharma Inc.; Corporate Parent Strides Pharma Asia Pte Ltd., Singapore for Strides Pharma Global PTE Limited filed by Strides Pharma Global PTE Limited, Strides Pharma Inc.. (Belgam, Neal) |
| Jan 17, 2018 | 7 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, by Strides Pharma Global PTE Limited, Strides Pharma Inc..(Ormerod, Eve) Modified on 1/18/2018 (nms). |
| Dec 5, 2017 | N/A | SO ORDERED (0) |
| Dec 4, 2017 | 6 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to the Complaint to January 17, 2018 - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Bourke, Mary) |
| Nov 29, 2017 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Nov 21, 2017 | 1 | Complaint (37) |
| Nov 21, 2017 | 1 | Exhibit O (19) |
| Nov 21, 2017 | 1 | Exhibit P (31) |
| Nov 21, 2017 | 1 | Exhibit Q (31) |
| Nov 21, 2017 | 1 | Exhibit R (27) |
| Nov 21, 2017 | 1 | Exhibit S (26) |
| Nov 21, 2017 | 1 | Exhibit T (7) |
| Nov 21, 2017 | 1 | Exhibit U (4) |
| Nov 21, 2017 | 1 | Civil Cover Sheet (2) |
| Nov 21, 2017 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lmm) |
| Nov 21, 2017 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/18/2017. Date of Expiration of Patent: 12/3/2028.Thirty Month Stay Deadline: 4/18/2020. (lmm) |
| Nov 21, 2017 | 4 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,906,519; 7,935,731; 8,093,298; 7,964,648; 8,093,297. (lmm) |
| Nov 21, 2017 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Takeda Pharmaceutical Company Limited, Corporate Parent Takeda Pharamceuticals International AG for Takeda Pharmaceuticals U.S.A., Inc. filed by Takeda Pharmaceuticals U.S.A., Inc.. (lmm) |
| Nov 21, 2017 | 1 | Exhibit N (19) |
| Nov 21, 2017 | 1 | Exhibit M (35) |
| Nov 21, 2017 | 1 | Exhibit L (36) |
| Nov 21, 2017 | 1 | Exhibit K (28) |
| Nov 21, 2017 | 1 | Exhibit J (26) |
| Nov 21, 2017 | 1 | Exhibit I (16) |
| Nov 21, 2017 | 1 | Exhibit H (16) |
| Nov 21, 2017 | 1 | Exhibit G (27) |
| Nov 21, 2017 | 1 | Exhibit F (29) |
| Nov 21, 2017 | 1 | Exhibit E (19) |
| Nov 21, 2017 | 1 | Exhibit D (16) |
| Nov 21, 2017 | 1 | Exhibit C (23) |
| Nov 21, 2017 | 1 | Exhibit B (16) |
| Nov 21, 2017 | 1 | Exhibit A (25) |
| Nov 21, 2017 | 1 | Main Document (37) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Strides Pharma Global PTE Limited, Strides Pharma Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2270411.) - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Civil Cover Sheet)(lmm) |
| Nov 21, 2017 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Strides Pharma Global PTE Limited on 11/21/2017; Strides Pharma Inc. on 11/21/2017. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (lmm) |
| Nov 21, 2017 | 1 | Complaint* (1) |
